Trial Profile
Impact of oral controlled release flecainide acetate capsules on health-related QoL [quality of life] in patients with paroxysmal atrial fibrillation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Sep 2006
Price :
$35
*
At a glance
- Drugs Flecainide (Primary)
- Indications Atrial fibrillation; Paroxysmal atrial fibrillation
- Focus Therapeutic Use
- 15 Sep 2006 Status change
- 06 Nov 2005 New trial record.